Thema
Antibodies, Monoclonal, Humanized
10.877
Antibodies, Monoclonal
10.799
Journal Article
9.000
Antineoplastic Agents
2.953
Research Support, Non-U.S. Gov't
2.905
Review
2.856
2S9ZZM9Q9V
2.428
Bevacizumab
2.428
EC 2.7.10.1
2.338
P188ANX8CK
2.210
Trastuzumab
2.210
Angiogenesis Inhibitors
1.754
Case Reports
1.626
Receptor, ErbB-2
1.338
Vascular Endothelial Growth Factor A
1.328
Cetuximab
1.231
PQX0D8J21J
1.231
Letter
1.172
Adalimumab
1.102
FYS6T7F842
1.101
Immunoglobulin G
1.073
ErbB Receptors
965
Antibodies, Neoplasm
885
3A189DH42V
872
Alemtuzumab
872
Tumor Necrosis Factor-alpha
848
Immunosuppressive Agents
831
Comparative Study
783
Comment
758
Klinische Studie
710
Infliximab
681
B72HH48FLU
680
Multicenter Study
661
Antirheumatic Agents
626
Randomized Controlled Trial
617
Research Support, N.I.H., Extramural
571
Receptors, Tumor Necrosis Factor
567
Etanercept
552
OP401G7OJC
552
Quinazolines
497
Antibodies, Anti-Idiotypic
450
CUJ2MVI71Y
437
Daclizumab
437
Fluorouracil
430
U3P01618RT
430
2P471X1Z11
429
Omalizumab
429
English Abstract
428
Clinical Trial, Phase II
405
XX2MN88N5D
382
mehr ...